600867 Stock Overview
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Tonghua Dongbao Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.73 |
| 52 Week High | CN¥12.48 |
| 52 Week Low | CN¥7.02 |
| Beta | 0.27 |
| 11 Month Change | 11.49% |
| 3 Month Change | 7.64% |
| 1 Year Change | -26.58% |
| 33 Year Change | -25.19% |
| 5 Year Change | -41.05% |
| Change since IPO | 906.48% |
Recent News & Updates
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Pretty Healthy Balance Sheet
Oct 22
Tonghua Dongbao Pharmaceutical Co., Ltd.'s (SHSE:600867) Earnings Haven't Escaped The Attention Of Investors
Sep 30Recent updates
Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Pretty Healthy Balance Sheet
Oct 22Tonghua Dongbao Pharmaceutical Co., Ltd.'s (SHSE:600867) Earnings Haven't Escaped The Attention Of Investors
Sep 30Some May Be Optimistic About Tonghua Dongbao Pharmaceutical's (SHSE:600867) Earnings
Sep 06Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Analysts Just Slashed This Year's Estimates
Sep 05Calculating The Intrinsic Value Of Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867)
Aug 22Tonghua Dongbao Pharmaceutical (SHSE:600867) Has A Rock Solid Balance Sheet
Jun 19Improved Earnings Required Before Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) Shares Find Their Feet
May 23Shareholder Returns
| 600867 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.0% | -2.6% | -2.1% |
| 1Y | -26.6% | -2.4% | 6.7% |
Return vs Industry: 600867 underperformed the CN Pharmaceuticals industry which returned -1.1% over the past year.
Return vs Market: 600867 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 600867 volatility | |
|---|---|
| 600867 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CN Market | 12.4% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 600867 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600867's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 3,196 | Sheng Leng Chun | www.thdb.com |
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices.
Tonghua Dongbao Pharmaceutical Co., Ltd. Fundamentals Summary
| 600867 fundamental statistics | |
|---|---|
| Market cap | CN¥17.02b |
| Earnings (TTM) | CN¥341.31m |
| Revenue (TTM) | CN¥2.43b |
49.9x
P/E Ratio7.0x
P/S RatioIs 600867 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600867 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.43b |
| Cost of Revenue | CN¥547.28m |
| Gross Profit | CN¥1.88b |
| Other Expenses | CN¥1.54b |
| Earnings | CN¥341.31m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 18, 2024
| Earnings per share (EPS) | 0.18 |
| Gross Margin | 77.49% |
| Net Profit Margin | 14.04% |
| Debt/Equity Ratio | 7.7% |
How did 600867 perform over the long term?
See historical performance and comparison